OA07.08 HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed, Phase II Platform Study in Patients with NSCLC, who Progressed on Anti-PD(L)1 Therapy
| Autor: | Besse, B., Awad, M., Forde, P., Thomas, M., Park, K., Goss, G., Rizvi, N., Huemer, F., Hochmair, M., Bennouna, J., Cosaert, J., Szucs, Z., Mortimer, P., Hobson, R., Sachsenmeier, K., Dean, E., Ambrose, H., Hayward, C., Dressman, M., Barry, S., Heymach, J. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2021 16(3) Supplement:S118-S119 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|